Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
VISTNVISTIN PHARMA ASA | 1.09 B NOK | 24.5 NOK | −2.00% | 2.72 K | 0.21 | 17.69 | 1.39 NOK | +37.91% | 2.04% | Health technology | — |
NYKDNYKODE THERAPEUTICS ASA | 887.55 M NOK | 2.718 NOK | −1.88% | 2.38 M | 0.37 | — | −1.27 NOK | +22.29% | 0.00% | Health technology | Buy |
BGBIOBERGENBIO ASA | 390.05 M NOK | 9.980 NOK | −3.75% | 675.17 K | 1.06 | — | −4.91 NOK | +85.91% | 0.00% | Health technology | Buy |
LYTIXLYTIX BIOPHARMA AS | 337.35 M NOK | 6.80 NOK | +6.25% | 76.34 K | 1.48 | — | −1.85 NOK | +24.63% | 0.00% | Health technology | — |
ULTIULTIMOVACS ASA | 74.3 M NOK | 2.160 NOK | −4.85% | 403.71 K | 1.00 | — | −4.34 NOK | +26.84% | 0.00% | Health technology | Sell |
AABSARCTIC BIOSCIENCE AS | 50.74 M NOK | 2.00 NOK | −3.85% | 52.35 K | 0.79 | — | −1.91 NOK | −27.80% | 0.00% | Health technology | Neutral |